CMND
CLEARMIND MEDCN (CMND)
NASDAQ
$2.85-$0.07 (-2.53%)
Price as of Jun 03, 2026 7:15 PM EDT
  • $3.6M
    Market Cap
  • -99.23%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
10/31/2025
10/31/2024
10/31/2023
10/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
4.4M
-8.34%
4.8M
N/A
N/A
N/A
Research and Development Expense
-2.1M
+48.72%
-1.4M
-10.45%
-1.5M
-63.28%
-4.2M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
3.6M
-17.23%
4.4M
-8.34%
4.8M
+9.98%
4.3M
N/A
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
-8.5M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-3,857
-28.39%
-5,386
N/A
N/A
N/A
-19,678
N/A
Interest Income and Expense and Net
-3,857
-28.39%
-5,386
N/A
0
+100.00%
-19,678
N/A
Total Nonoperating Income and Expense
3,857
-28.39%
5,386
-67.47%
16,555
-15.87%
19,678
N/A
Income before Taxes
-3.9M
-26.60%
-5.3M
-39.05%
-8.6M
-8.39%
-9.4M
N/A
Income Taxes
70,445
-81.36%
377,966
+2,075.72%
17,372
-57.37%
40,754
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.9M
-26.60%
-5.3M
-39.05%
-8.6M
-8.39%
-9.4M
N/A
Net Income from Continuing Operations Applicable to Common
-3.9M
-26.60%
-5.3M
-39.05%
-8.6M
-8.39%
-9.4M
N/A
Basic EPS and Net Income
-30.35
+1,695.86%
-1.69
-96.03%
-42.58
+488.12%
-7.24
N/A
Diluted EPS and Net Income
-30.35
+1,695.86%
-1.69
-96.03%
-42.58
+488.12%
-7.24
N/A
Basic Weighted Average Shares
127,093
-95.90%
3.1M
+1,431.07%
202,481
-84.43%
1.3M
N/A
Diluted Weighted Average Shares
127,093
-95.90%
3.1M
+1,431.07%
202,481
-84.43%
1.3M
N/A
Balance Sheet
Cash and Cash Equivalents
3.9M
-40.32%
6.6M
+21.12%
5.4M
+2,988.01%
175,768
N/A
Short-Term Investments
1.7M
+474.46%
289,388
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.6M
-18.62%
6.9M
+26.45%
5.4M
+2,988.01%
175,768
N/A
Total Current Assets
5.9M
-16.09%
7.1M
+22.33%
5.8M
+876.65%
593,312
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
1,727
-90.19%
17,610
N/A
Total Long-Term Assets
135,334
-19.05%
167,175
+5.33%
158,712
-70.32%
534,662
N/A
Total Assets
6.1M
-16.16%
7.3M
+21.87%
6.0M
+427.79%
1.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.9M
+18.37%
4.1M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
16,416
0.00%
16,416
N/A
N/A
N/A
N/A
N/A
Total Liabilities
4.9M
+17.90%
4.1M
-16.54%
5.0M
+88.43%
2.6M
N/A
Retained Earnings
-27.9M
+16.06%
-24.0M
+28.00%
-18.8M
+35.51%
-13.8M
N/A
Total Stockholders Equity
1.2M
-61.62%
3.1M
+215.98%
983,472
+165.15%
-1.5M
N/A
Total Shares Outstanding
158,076
-98.15%
8.5M
+19,290.73%
43,992
-96.67%
1.3M
N/A
Cash Flow
Cash from Operating Activities
-4.7M
-2.56%
-4.9M
-22.90%
-6.3M
+23.96%
-5.1M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-542,017
+127.65%
-238,097
+807.80%
-26,228
+245.42%
-7,593
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.6M
-58.07%
6.3M
-46.38%
11.7M
+1,570.15%
698,403
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-57.83%
-27.31%
-79.56%
-67.32%
-243.48%
N/A
N/A
N/A
Return on Equity
-179.39%
-30.17%
-256.89%
-107.84%
3,277.26%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.22
-29.11%
1.72
N/A
N/A
N/A
N/A
N/A
Cash Ratio
0.80
-49.59%
1.59
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow